126 related articles for article (PubMed ID: 37423611)
21. Diagnostic accuracy of stereotactic brain biopsy for intracranial neoplasia in dogs: Comparison of biopsy, surgical resection, and necropsy specimens.
Kani Y; Cecere TE; Lahmers K; LeRoith T; Zimmerman KL; Isom S; Hsu FC; Debinksi W; Robertson JL; Rossmeisl JH
J Vet Intern Med; 2019 May; 33(3):1384-1391. PubMed ID: 30990928
[TBL] [Abstract][Full Text] [Related]
22. Hypofractionated stereotactic radiotherapy for unifocal and multifocal recurrence of malignant gliomas.
McKenzie JT; Guarnaschelli JN; Vagal AS; Warnick RE; Breneman JC
J Neurooncol; 2013 Jul; 113(3):403-9. PubMed ID: 23589034
[TBL] [Abstract][Full Text] [Related]
23. Frameless stereotactic radiosurgery for the treatment of primary intracranial tumours in dogs.
Mariani CL; Schubert TA; House RA; Wong MA; Hopkins AL; Barnes Heller HL; Milner RJ; Lester NV; Lurie DM; Rajon DA; Friedman WA; Bova FJ
Vet Comp Oncol; 2015 Dec; 13(4):409-23. PubMed ID: 24007303
[TBL] [Abstract][Full Text] [Related]
24. Stereotactic radiotherapy (10 Gy X 3) for canine nonlymphomatous intranasal tumors is associated with prolonged survival and minimal risk of severe radiotoxicity.
Nolan MW; Berman AR; Watson-Skaggs ML; Quinn CN; Marcus KL; Russell K; Yoshikawa H; Olby NJ; Gieger TL
J Am Vet Med Assoc; 2022 Jun; 260(12):1496-1506. PubMed ID: 35905155
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (phase I/II study).
Laing RW; Warrington AP; Graham J; Britton J; Hines F; Brada M
Radiother Oncol; 1993 Apr; 27(1):22-9. PubMed ID: 8327729
[TBL] [Abstract][Full Text] [Related]
26. Canine presumed glial brain tumours treated with radiotherapy: Is there an inferior outcome in tumours contacting the subventricular zone?
Rohrer Bley C; Staudinger C; Bley T; Marconato L; Sabattini S; Beckmann K
Vet Comp Oncol; 2022 Mar; 20(1):29-37. PubMed ID: 33900018
[TBL] [Abstract][Full Text] [Related]
27. Treatment of MRI-Diagnosed Trigeminal Peripheral Nerve Sheath Tumors by Stereotactic Radiotherapy in Dogs.
Hansen KS; Zwingenberger AL; Théon AP; Pfeiffer I; Kent MS
J Vet Intern Med; 2016 Jul; 30(4):1112-20. PubMed ID: 27279132
[TBL] [Abstract][Full Text] [Related]
28. Hypofractionated stereotactic radiotherapy in the management of recurrent glioma.
Shepherd SF; Laing RW; Cosgrove VP; Warrington AP; Hines F; Ashley SE; Brada M
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):393-8. PubMed ID: 9069312
[TBL] [Abstract][Full Text] [Related]
29. Prognostic histopathologic features of canine glial tumors.
Merickel JL; Pluhar GE; Rendahl A; O'Sullivan MG
Vet Pathol; 2021 Sep; 58(5):945-951. PubMed ID: 34219560
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of stereotactic radiotherapy as salvage treatment for recurrent malignant gliomas.
Ekici K; Ozseker N; Mayadagli A; Erdogan Kocak M; Olmezoglu A
J BUON; 2014; 19(4):1029-34. PubMed ID: 25536612
[TBL] [Abstract][Full Text] [Related]
31. Safety and feasibility of the NanoKnife system for irreversible electroporation ablative treatment of canine spontaneous intracranial gliomas.
Rossmeisl JH; Garcia PA; Pancotto TE; Robertson JL; Henao-Guerrero N; Neal RE; Ellis TL; Davalos RV
J Neurosurg; 2015 Oct; 123(4):1008-25. PubMed ID: 26140483
[TBL] [Abstract][Full Text] [Related]
32. Characteristics and outcomes for 61 cats that underwent either surgery or stereotactic radiotherapy as treatment for intracranial meningioma (2005-2017).
Tichenor M; Hearon K; Selmic LE
J Am Vet Med Assoc; 2024 Jan; 262(1):1-8. PubMed ID: 37863102
[TBL] [Abstract][Full Text] [Related]
33. Naturally Occurring Canine Glioma as a Model for Novel Therapeutics.
Hubbard ME; Arnold S; Bin Zahid A; McPheeters M; Gerard O'Sullivan M; Tabaran AF; Hunt MA; Pluhar GE
Cancer Invest; 2018; 36(8):415-423. PubMed ID: 30234401
[TBL] [Abstract][Full Text] [Related]
34. A retrospective analysis of stereotactic body radiation therapy for canine heart base tumors: 26 cases.
Kruckman-Gatesy CR; Ames MK; Griffin LR; Boss MK; Rao S; Leary D; LaRue SM
J Vet Cardiol; 2020 Feb; 27():62-77. PubMed ID: 32078943
[TBL] [Abstract][Full Text] [Related]
35. Impact of radiation dose and pre-treatment pain levels on survival in dogs undergoing radiotherapy with or without chemotherapy for presumed extremity osteosarcoma.
Nolan MW; Green NA; DiVito EM; Lascelles BDX; Haney SM
Vet Comp Oncol; 2020 Dec; 18(4):538-547. PubMed ID: 32048435
[TBL] [Abstract][Full Text] [Related]
36. Outcome of intensity-modulated radiation therapy-based stereotactic radiation therapy for treatment of canine nasal carcinomas.
Fox-Alvarez S; Shiomitsu K; Lejeune AT; Szivek A; Kubicek L
Vet Radiol Ultrasound; 2020 May; 61(3):370-378. PubMed ID: 32189433
[TBL] [Abstract][Full Text] [Related]
37. Stereotactic radiation therapy for treatment of canine intracranial meningiomas.
Griffin LR; Nolan MW; Selmic LE; Randall E; Custis J; LaRue S
Vet Comp Oncol; 2016 Dec; 14(4):e158-e170. PubMed ID: 25524449
[TBL] [Abstract][Full Text] [Related]
38. Treatment of intracranial neoplasia in dogs using higher doses: A randomized controlled trial comparing a boosted to a conventional radiation protocol.
Staudinger C; Meier V; Beckmann K; Körner M; Rohrer Bley C
J Vet Intern Med; 2022 Jul; 36(4):1353-1364. PubMed ID: 35775129
[TBL] [Abstract][Full Text] [Related]
39. Safety and feasibility of stereotactic radiotherapy using computed portal radiography for canine intracranial tumors.
Rancilio NJ; Bentley RT; Plantenga JP; Parys MM; Crespo BG; Moore GE
Vet Radiol Ultrasound; 2018 Mar; 59(2):212-220. PubMed ID: 29205634
[TBL] [Abstract][Full Text] [Related]
40. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
